GMED - Globus Medical - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GMED is currently covered by 13 analysts with an average price target of $104.13. This is a potential upside of $11.41 (12.31%) from yesterday's end of day stock price of $92.72.

Globus Medical's activity chart (see below) currently has 206 price targets and 187 ratings on display. The stock rating distribution of GMED is 50% HOLD, 43.75% BUY and 6.25% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 94.76% with an average time for these price targets to be met of 301.74 days.

Highest price target for GMED is $115, Lowest price target is $90, average price target is $104.13.

Most recent stock forecast was given by CRAIG BIJOU from BAML on 10-Jan-2025. First documented stock forecast 17-Jun-2013.

Currently out of the existing stock ratings of GMED, 32 are a HOLD (50%), 28 are a BUY (43.75%), 4 are a SELL (6.25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Sell

$97

$4.28 (4.62%)

$80

22 days ago
(10-Jan-2025)

7/10 (70%)

$7.56 (8.45%)

529

Hold

23 days ago
(09-Jan-2025)

3/3 (100%)

$10.44 (17.24%)

499

Hold

$90

$-2.72 (-2.93%)

$79

1 months 14 days ago
(18-Dec-2024)

24/25 (96%)

$4.91 (5.77%)

347

Buy

$115

$22.28 (24.03%)

$100

1 months 15 days ago
(17-Dec-2024)

9/13 (69.23%)

$33.17 (40.54%)

347

Buy

$91

$-1.72 (-1.86%)

$78

1 months 20 days ago
(12-Dec-2024)

15/15 (100%)

$7.36 (8.80%)

133

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GMED (Globus Medical) average time for price targets to be met?

On average it took 301.74 days on average for the stock forecasts to be realized with a an average price target met ratio 94.76

Which analyst has the current highest performing score on GMED (Globus Medical) with a proven track record?

JASON WITTES

Which analyst has the most public recommendations on GMED (Globus Medical)?

Jason Wittes has 10 price targets and 8 ratings on GMED

Which analyst is the currently most bullish on GMED (Globus Medical)?

Jason Wittes with highest potential upside - $22.28

Which analyst is the currently most reserved on GMED (Globus Medical)?

Steven Lichtman with lowest potential downside - -$69.72

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?